Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;108:2666-2671
Published online before print October 27, 2003, doi: 10.1161/01.CIR.0000097115.61309.59
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/21/2666    most recent
01.CIR.0000097115.61309.59v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Agostoni, P.
Right arrow Articles by Wasserman, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agostoni, P.
Right arrow Articles by Wasserman, K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CARBON MONOXIDE
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Exercise/exercise testing/rehabilitation

(Circulation. 2003;108:2666.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Exercise-Induced Pulmonary Edema in Heart Failure

Piergiuseppe Agostoni, MD, PhD; Gaia Cattadori, MD; Michele Bianchi, MD; Karlman Wasserman, MD, PhD

From Centro Cardiologico Monzino (P.A., G.C., M.B.), IRCCS, Istituto di Cardiologia, Università di Milano, Milan, Italy; and Division of Respiratory and Critical Care Medicine (K.W.), Department of Medicine, Harbor-University of California Los Angeles Medical Center, Torrance, Calif.

Correspondence to Piergiuseppe Agostoni, MD, PhD, Centro Cardiologico Monzino, IRCCS, Istituto di Cardiologia, Università di Milano, Via Parea 4, 20138 Milan, Italy. E-mail Piergiuseppe.agostoni{at}CCFM.it

Received May 14, 2003; de novo received July 10, 2003; accepted August 20, 2003.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background— In heart failure (HF) patients, exercise may increase pulmonary capillary hydrostatic pressure and thereby generate pulmonary edema. If pulmonary edema developed, alveolar-capillary membrane conductance (DM), measured immediately after exercise, would decrease. To test this hypothesis, we measured DM before and at 2 and 60 minutes after exercise.

Methods and Results— We studied 10 HF patients with exercise-induced periodic breathing, 10 with peak VO2 <=15 mL · min-1 · kg-1 (severe HF), 10 with VO2=15 to 20 mL · min-1 · kg-1 (moderate HF), and 10 normal subjects (control). Using the Roughton-Forster technique, we measured carbon monoxide diffusion capacity (DLCO) and its components, capillary blood volume (VC) and DM, at rest and 2 and 60 minutes after exercise. At rest, DLCO and DM were lowest in periodic breathing and highest in control subjects. DM decreased in periodic breathing, severe HF, and moderate HF (-7.83±3.98, -5.57±2.03, and -3.85±3.53 mL · min-1 · mm Hg-1, respectively; P<0.01) at 2 minutes after exercise but not in control subjects. VC increased in all groups at 2 minutes and remained elevated at 60 minutes only in periodic breathing. DM/VC was decreased in periodic breathing, severe HF, and moderate HF at 2 minutes but not in control subjects. DM and DM/VC remained low at 60 minutes only in periodic breathing.

Conclusions— DM decreases after exercise in HF patients but not in control subjects, which suggests a decrease in conductance across the alveolar-capillary barrier, as with pulmonary edema. The reductions were most marked in HF patients with periodic breathing and less reduced in less severe HF.


Key Words: heart failure • exercise • edema • lung


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
In patients with left ventricular failure during exercise, pulmonary vascular pressure increases more markedly than in normal subjects.1,2 Indeed, the left ventricle dilates early and significantly during exercise1 because of an increase in venous return, systemic arterial pressure, catecholamine levels, and central blood volume and failure of the heart to keep up with increased cardiac work that results from an increased heart rate and shortened diastolic period. Therefore, leakage of fluid from the pulmonary vasculature into the pulmonary interstitium could be enhanced depending on the increase in transcapillary fluid pressure. The amount of pulmonary extravascular fluid is a function of the balance between pulmonary capillary fluid filtration and fluid removal from the pulmonary interstitium.3,4 The potential for developing exercise-induced pulmonary edema as a result of an increase in transcapillary fluid pressure should depend on the level of exercise performed and the severity of heart failure (HF).5 Fluid should be reabsorbed from the interstitial space and alveolus when transcapillary fluid pressure deceases in exercise recovery. The time to remove the exercise-induced increase in pulmonary edema, when exercise is terminated, should depend on the reversal of the exercise-induced pressure elevation and the quantity of fluid transudated during exercise. A more prolonged recovery time should take place in more compromised patients. To test this hypothesis, we measured carbon monoxide diffusion capacity (DLCO) and its components, with particular attention to specific membrane conductance (DM), before exercise and 2 minutes and 1 hour after exercise in HF patients and a matched group of normal subjects. Our objective was to determine whether membrane conductance (DM) was reduced during the postexercise period in HF compared with normal control subjects, and if so, whether its decrease was related to the severity of HF.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Study Population
Thirty patients with chronic HF and 10 healthy volunteers participated in the study. Patients belonged to a cohort of HF subjects regularly followed up at our HF unit. All subjects were evaluated previously by cardiopulmonary exercise testing (CPET) in our laboratory. Study inclusion criteria for chronic HF patients were New York Heart Association class II or III; optimized, individually tailored drug treatment; stable clinical conditions for at least 2 months as confirmed by absence of relevant edema, stable body weight, and urinary output; capability of performing a CPET; and absence of history or clinical documentation of pulmonary embolism or primary valvular heart disease, pericardial disease, severe obstructive lung disease, significant peripheral vascular disease, exercise-induced angina, ST changes, or severe arrhythmias. Heart failure patients were grouped according to the following criteria: (1) periodic breathing (PB), defined as presence of exercise-induced periodic oscillation in ventilation, VO2, and VCO2 and the gas exchange ratio; (2) severe HF, defined as HF patients with peak VO2 <15 mL · min-1 · kg-1 without oscillatory gas exchange; and (3) moderate HF, defined as HF patients with peak VO2 between 15 and 20 mL · min-1 · kg-1. Patients with peak VO2 >20 mL · min-1 · kg-1 were not included in the study. Normal subjects, consisting of hospital personnel and patients’ relatives, served as controls. All had previous experience with CPET in our laboratory. Subjects’ characteristics are reported in Table 1. Left ventricular ejection fraction was evaluated by echocardiography (Table 1). The study was approved by the local ethics committee. All subjects provided written informed consent to participate in the study.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Descriptive Characteristics of HF Patients and Normal Subjects

Lung Diffusion
All subjects were evaluated by standard pulmonary function tests, which included DLCO measured with the single breath–constant expiratory flow technique (Sensor Medics 2200).6 Diffusion subcomponents, capillary volume (VC) and DM, were also measured by application of the Roughton and Forster method.7 For this purpose, subjects inspired gas mixtures containing 0.3% CH4 and 0.3% CO, with 3 different oxygen fractions equal to 20%, 40%, and 60%, respectively, and balanced with nitrogen.

CPET Ramp Protocol
A CPET in which work rate was increased in a ramp pattern after 3 minutes of rest and 3 minutes of unloaded cycling was performed on a cycle ergometer (Ergo 800S Sensor Medics). Expiratory O2, CO2, and ventilation (VE) were measured breath by breath. A 12-lead ECG was also recorded from which heart rate was obtained (V-Max, Sensor Medics). The patients were strongly encouraged to perform a maximal test, but they determined when their symptoms were so severe that it was necessary to stop cycling. At the end of the test, the patient was asked to indicate the major symptom that led to his or her stopping the exercise. Specifically, we inquired about chest pain, fatigue, and dyspnea. The rate of work rate increase during testing was decided on the basis of the patient’s clinical condition and the results of previous tests. The aim was to achieve peak exercise in {approx}10 minutes. If test duration was >12 or <8 minutes, the test was repeated the next day with the work rate increase adjusted as needed. Peak exercise was considered the highest VO2 achieved. Anaerobic threshold was measured with the V-slope analysis from the plot of VCO2 versus VO2 on equal scales.8 The anaerobic threshold value was confirmed by ventilatory equivalents (increase of VE/VO2 with a constant VE/VCO2) and end-tidal pressure (increase of end-tidal PO2 with constant end-tidal PCO2). The VO2/work rate relationship was evaluated throughout the entire exercise, during the ramping period, after elimination of the increase in work rate during the first 45 seconds to account for the time constant for the VO2 response to the work rate increase.9 The VE versus VCO2 slope was calculated as the slope of the linear relationship between VE and VCO2 from the beginning of loaded exercise to the end of the isocapnic buffering period. Two experts independently read each test, and the results were averaged.

CPET Constant Work-Rate Protocol
A constant work rate CPET was also performed. The work rate of the constant work rate CPET was selected as that which gave a VO2 approximately midway between peak exercise and the anaerobic threshold, according to the following formula:


where WRc is work rate of the constant work rate test, PeakWR is peak exercise work rate-0.75xramp work rate/minute, ATWR is anaerobic threshold work rate-0.75xramp work rate/minute, and 0.75 is the average calculated time constant, in minutes, for VO2 in response to work rate increase.9 The patients were asked to perform the constant work rate test for 10 minutes.

Study Design
Day 1
All subjects underwent careful clinical evaluation, assessment of resting pulmonary function, and a learning session for DLCO measurements. Afterward, each subject underwent a CPET with ramp protocol to group patients according to HF severity and to obtain data to calculate the work rate for the constant work rate protocol to be used on day 2.

Day 2
Patients underwent a 10-minute CPET constant work rate protocol. DLCO, DM, and VC were measured while subjects were sitting on the cycle ergometer before the constant work rate CPET and 2 to 8 minutes (referred to as 2 minutes or "early") and 1 hour later. If the DLCO measurements for the 3 FIO2 tests did not fit the theoretical 3-point linear analysis between 1/DLCO and FIO2, measurements were repeated.

Statistical Analysis
Data reported are mean±SEM. Intragroup and intergroup differences were evaluated by ANOVA followed by unpaired or paired t test as appropriate. Differences from zero were evaluated by difference analysis.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Two patients stopped the exercise because of dyspnea, whereas all other reasons for stopping were because of fatigue (patients with exercise-induced chest pain were excluded from the study). Results of the CPET ramp protocol are reported in Table 2. HF severity was greatest in PB patients and lowest in moderate HF patients. Peak VO2, VO2 at anaerobic threshold, and peak work rate achieved were lowest in PB patients and increased progressively with less severe HF to normal values for normal subjects (Table 2). The increases in exercise capacity from PB patients to severe HF patients to moderate HF patients and finally to normal subjects were significant.10–13


View this table:
[in this window]
[in a new window]
 
TABLE 2. Results of CPET Ramp Protocol

The {Delta}VO2/{Delta}work rate relationship likewise increased progressively from the lowest values in PB patients to normal values of 9.9 mL · min-1 · W-1 in normal subjects. Thus, PB patients had the greatest decrease in O2 utilization, and this deficit became less with less severe HF.9

The slope of VE versus VCO2, a strong HF prognostic indicator independent of peak VO2,14,15 was significantly elevated in PB patients, elevated but to a smaller degree in severe HF patients, and normal in moderate HF patients and normal subjects (Table 2). The work rate of the constant work rate exercise was lower the greater the severity of the disease (Table 3).


View this table:
[in this window]
[in a new window]
 
TABLE 3. Results of CPET Constant Work Rate Protocol

The constant work rate CPET lasted, as programmed, for 10 minutes in all but 7 patients (2 PB patients, 3 severe HF patients, and 2 moderate HF patients); in these patients, constant CPET lasted at least 8 minutes. The VO2 reached at the end of the constant work rate exercise (Table 3) was approximately equal to the peak VO2 measured in the ramp protocol (Table 2).

At rest, DLCO and DM were highest in normal subjects, whereas they were lowest in PB patients (Figure 1). VC and DM/VC were similar among all 4 groups at rest, with a considerable intragroup data dispersion (Figure 1).



View larger version (22K):
[in this window]
[in a new window]
 
Figure 1. DLCO, DM, VC, and DM/VC at rest and 2 minutes and 1 hour after exercise in different groups. *P<0.02 vs rest; §P<0.05 vs rest; &P<0.02 vs control; $P<0.02 vs severe HF; £P<0.02 vs moderate HF. Recov indicates recovery.

At early (2 to 8 minutes) and late (1 hour) recovery from constant work rate exercise, DLCO did not change significantly. Normal subjects had increased DLCO shortly after exercise (Figure 2). DM decreased in all HF subjects immediately after exercise, in contrast to normal subjects (Figure 3). The reduction was most marked in PB patients. At 1 hour, DM remained low only in PB patients (Figure 3). VC increased in all groups immediately after exercise, with a greater increase in moderate HF patients (Figure 4). One hour after exercise, VC remained elevated only in PB patients (Figure 4). Immediately after exercise, DM/VC decreased in all HF groups but was unchanged in normal subjects (Figure 5). The reduction was greatest in PB patients (P<0.02 versus moderate and severe HF patients). DM/VC remained reduced at 1 hour into recovery only in PB patients (Figure 5).



View larger version (14K):
[in this window]
[in a new window]
 
Figure 2. DLCO changes from rest in different groups (2-minute recovery and 1-hour recovery). *P<0.01 vs rest. Per Br indicates periodic breathing (PB); Sev, severe; Mod, moderate; and Recov, recovery.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 3. Membrane conductance (DM) changes from rest in different groups; symbols and abbreviations as in Figure 2. *P<0.01 vs rest.



View larger version (12K):
[in this window]
[in a new window]
 
Figure 4. Capillary volume (VC) changes from rest in different groups; symbols and abbreviations as in Figure 2. *P<0.01 vs rest; {Delta}P<0.02 vs other groups.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 5. Membrane conductance/capillary volume (DM/VC) changes from rest in different groups; symbols and abbreviations as in Figure 2. *P<0.01 vs rest; {Delta}P<0.02 vs other groups.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
Physiological evidence of exercise-induced pulmonary edema, evaluated as changes in the membrane component of diffusion capacity, are present in HF subjects and, to a greater extent, in HF patients with PB. Apparently, complete reabsorption of lung edema fluid needs more than 1 hour for DM and DM/VC to return to preexercise levels in HF patients with PB who undergo exercise. Normal individuals do not develop postexercise reductions in DM or DM/VC.

HF patients were grouped according to peak VO2 or to the presence of exercise-induced PB. The latter group had more severe HF as suggested by several findings, including (1) higher New York Heart Association class, (2) lower resting DLCO and DM, (3) lower peak VO2 and VO2 at anaerobic threshold, (4) lower work rate achieved, (5) lower {Delta}VO2/{Delta}work rate relationship, and (6) higher VE versus VCO2 slope. Although the New York Heart Association classification has been the most used HF classification in clinical medicine for many years,16 other physiological measures of HF prognosis have been correlated with exercise capacity, including peak VO2, VO2 at anaerobic threshold, work rate achieved,10–13 {Delta}VO2/{Delta}work rate relationship (an indicator of efficiency of oxygen delivery to peripheral muscles), and finally, the slope of VE versus VCO2 from unloaded cycling to the ventilatory compensation point, an indicator of the efficiency of ventilation.14–17 It appears that DLCO, particularly the change in the DM component with exercise, can be included among predictors of HF severity and prognosis.17–21

To induce pulmonary edema, we asked all subjects to perform a high work rate constant CPET that was intended to last 10 minutes. Indeed, the work rate chosen was between the anaerobic threshold and peak exercise. Almost all subjects performed 10 minutes of exercise at this level. VO2 was similar to peak VO2 measured with the ramp-protocol CPET.

Shortly after heavy exercise, DLCO increased in normal subjects owing to increases in both VC and DM, albeit the latter was only a trend. DLCO did not change in HF patients shortly after exercise. This observation is consistent with the fact that unlike chronic lung disease patients and elite athletes, desaturation of hemoglobin is rarely observed during exercise in stable HF patients and normal subjects.21 This is documented even in patients with severe HF.22 Several facts may explain why hemoglobin desaturation is not observed in patients with HF during exercise: (1) the reduction in DM is relatively small, (2) the pulmonary transit time for red blood cells is slow, and (3) VC increases. Indeed, in HF, the observed reduction of DM is accompanied by an increase in VC (Figure 4)23 so that DLCO remains constant. The exercise-induced increase in VC is presumably due to pulmonary vessel recruitment.23 This occurred to a lesser degree in patients with more severe HF, which suggests a limited capability to recruit pulmonary vessels in patients with severe HF. A significant reduction of DLCO was observed in subjects with exercise-induced PB and severe HF 1 hour after exercise (Figure 2). This was due to persistence of a reduced DM with a smaller VC increase compared with the early recovery measurement.

In chronic HF patients, the low values of DLCO and DM and their changes due to therapy are not thought to be related to alveolar-capillary fluid content.24 In contrast, exercise-induced acute, short-lasting reductions in DM and DM/VC most likely are related to pulmonary edema formation during exercise. Indeed, fluid accumulation during pulmonary edema formation is a progressive phenomenon caused by the imbalance between fluid filtration and removal. In the beginning, fluid accumulates in the more compliant interstitial compartment that surrounds bronchioles, arterioles, and venules. Later, fluid accumulates in the less compliant interstitial space of the alveolar-capillary septum, which, if the interstitial pressure increase is enough, might lead to alveolar flooding.25 The changes in DM and DM/VC imply that normal individuals do not develop pulmonary edema during 10 minutes of heavy exercise, whereas HF patients commonly do so. It also appears that the tendency to develop pulmonary edema with exercise is greater in patients with PB. It had been proposed that HF patients with PB are likely functioning on the descending limb of the Starling curve; therefore, they would be more readily subject to increases in pulmonary capillary pressure and exercise-induced pulmonary edema when venous return increases with exercise.2

Patients with exercise-induced PB apparently reabsorb pulmonary edema in recovery relatively slowly, so that even after 1 hour, DM remained reduced. This supports the widely held perspective that HF patients with PB are among the most severe HF patients and likely need prolonged observation after exercise. Because exercise-induced PB is detectable from the beginning of exercise, disappearing as work rate is increased above the anaerobic threshold, assessment of HF in this group does not require a maximal effort exercise test to properly classify the severity of HF in these patients.26

In conclusion, we found that DM and DM/VC decreased transiently after heavy-intensity exercise in HF patients but not in control subjects. This decrease in conductance across the alveolar-capillary barrier is consistent with development of exercise-induced pulmonary edema. The reductions were transient but were most marked and longer lasting in HF patients with an exercise-induced PB or oscillatory breathing pattern.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Shabetai R. The role of the pericardium in the pathophysiology of heart failure. In: Hosenpud JD, Greenberg BH. Congestive Heart Failure. New York, NY: Springer Verlag; 1994: 95–125.
  2. Janicki JS. Influence of the pericardium and left ventricular interdependence on left ventricular systolic and diastolic function in patients with heart failure. Circulation. 1990; 81 (suppl 3): III-15–III-20.[Medline] [Order article via Infotrieve]
  3. Higginbotham MB, Morris KG, Conn EH, et al. Determinants of variable exercise performance among patients with severe left ventricular dysfunction. Am J Cardiol. 1983; 51: 52–60.[CrossRef][Medline] [Order article via Infotrieve]
  4. Butler J, Chomsky DB, Wilson JR. Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol. 1999; 34: 1802–1806.[Abstract/Free Full Text]
  5. Weaver LJ, Carrico CJ. Congestive heart failure and edema. In: Staub NC, Taylor AE. Edema. New York, NY: Raven Press; 1984.
  6. Huang YT, Helms MJ, MacIntyre NR. Normal values for single exhalation diffusing capacity and pulmonary capillary blood flow in sitting, supine positions, and during mild exercise. Chest. 1994; 105: 501–508.[Abstract/Free Full Text]
  7. Roughton FJW, Forster FE. Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in human lung, with special reference to true diffusing capacity of blood in the lung capillaries. J Appl Physiol. 1957; 11: 290–302.[Abstract/Free Full Text]
  8. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting the anaerobic threshold by gas exchange. J Appl Physiol. 1986; 60: 2020–2027.[Abstract/Free Full Text]
  9. Hansen JE, Sue DY, Oren A, et al. Relation of oxygen uptake to work rate in normal men and men with circulatory disorders. Am J Cardiol. 1987; 59: 669–674.[CrossRef][Medline] [Order article via Infotrieve]
  10. Weber K, Kinasewitz G, Janicki J, et al. Oxygen utilization and ventilation during exercise in patients with chronic congestive heart failure. Circulation. 1982; 65: 1213–1223.[Abstract/Free Full Text]
  11. Szlachcic J, Massie B, Kramer B, et al. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol. 1985; 55: 1037–1042.[CrossRef][Medline] [Order article via Infotrieve]
  12. Cohn J, Johnson G, Sjabetai R, et al, for the V-HEFT VA Cooperative Studies Group. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio and plasma norepinephrine as determinants of prognosis in heart failure. Circulation. 1993; 87: VI-5–VI-16.[Medline] [Order article via Infotrieve]
  13. Mancini D, LeJemtel T, Aaronson K. Peak VO2, a simple yet enduring standard. Circulation. 2000; 101: 1080–1082.[Free Full Text]
  14. Chua TP, Ponikowsky P, Anker SD, et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic congestive heart failure. J Am Coll Cardiol. 1997; 29: 1585–1590.[Abstract]
  15. Kleber F, Vietzke G, Wernecke KD, et al. Prognostic impact. Circulation. 2000; 101: 2803–2809.[Abstract/Free Full Text]
  16. Criteria Committee, New York Heart Association, Inc. Diseases of the Heart and Blood Vessels. Nomenclature and Criteria for Diagnosis. 6th ed. Boston, Mass: Little Brown & Co; 1964: 114.
  17. Sue DY, Oren A, Hansen JE, et al. Diffusing capacity for carbon monoxide as a predictor of gas exchange during exercise. N Engl J Med. 1987; 316: 1301–1306.[Abstract]
  18. Guazzi M, Pontone G, Brambilla R, et al. Alveolar capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure. Eur Heart J. 2002; 23: 467–476.[Abstract/Free Full Text]
  19. Chua TP, Piepoli M, Coats AJS. Alveolar-capillary membrane diffusing capacity and its role in the functional capacity of chronic congestive heart failure patients. Cardiologia. 1997; 42: 265–268.[Medline] [Order article via Infotrieve]
  20. Messner-Pellenc P, Brasileiro C, Ahmaidi S, et al. Exercise intolerance in patients with chronic heart failure: role of pulmonary diffusion limitation. Eur Heart J. 1995; 16: 201–209.[Abstract/Free Full Text]
  21. Agostoni PG, Bussotti M, Palermo P, et al. Does lung diffusion impairment affect exercise capacity in patients with heart failure? Heart. 2002; 88: 453–459.[Abstract/Free Full Text]
  22. Perego GB, Marenzi GC, Guazzi M, et al. Contribution of PO2, P50 and Hb in changes in arteriovenous O2 content during exercise in heart failure. J Appl Physiol. 1996; 80: 623–631.[Abstract/Free Full Text]
  23. Puri S, Baker L, Dutka DP, et al. Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Circulation. 1995; 91: 2769–2774.[Abstract/Free Full Text]
  24. Marenzi GC, Lauri G, Grazi M, et al. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol. 2001; 38: 963–968.[Abstract/Free Full Text]
  25. Givertz MM, Colucci WS, Braunwald E. Clinical aspects of heart failure: high output failure, pulmonary edema. In: Braunwald E, Zipes DP, Libby P. Heart Disease. Philadelphia, Pa: WB Saunders; 2001: 553–558.
  26. Ben-Dov I, Sietsema KE, Casaburi R, et al. Evidence that circulatory oscillation accompanies ventilatory oscillation during exercise in patients with heart failure. Am Rev Respir Dis. 1992; 145: 776–781.[Medline] [Order article via Infotrieve]



This article has been cited by other articles:


Home page
ChestHome page
P. Agostoni, A. Apostolo, and R. K. Albert
Mechanisms of Periodic Breathing During Exercise in Patients With Chronic Heart Failure
Chest, January 1, 2008; 133(1): 197 - 203.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Bartsch and J. S. R. Gibbs
Effect of Altitude on the Heart and the Lungs
Circulation, November 6, 2007; 116(19): 2191 - 2202.
[Full Text] [PDF]


Home page
ChestHome page
E. M. Snyder, S. T. Turner, and B. D. Johnson
{beta}2-Adrenergic Receptor Genotype and Pulmonary Function in Patients With Heart Failure.
Chest, November 1, 2006; 130(5): 1527 - 1534.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Agostoni, M. Bussotti, G. Cattadori, E. Margutti, M. Contini, M. Muratori, G. Marenzi, and C. Fiorentini
Gas diffusion and alveolar-capillary unit in chronic heart failure
Eur. Heart J., November 1, 2006; 27(21): 2538 - 2543.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Guazzi
Letter by Guazzi Regarding Article "Sleep and Exertional Periodic Breathing in Chronic Heart Failure: Prognostic Importance and Interdependence"
Circulation, July 18, 2006; 114(3): e53 - e53.
[Full Text] [PDF]


Home page
Exp PhysiolHome page
N. S. Cherniack and G. S. Longobardo
Mathematical models of periodic breathing and their usefulness in understanding cardiovascular and respiratory disorders
Exp Physiol, March 1, 2006; 91(2): 295 - 305.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Palermo, G. Cattadori, M. Bussotti, A. Apostolo, M. Contini, and P. Agostoni
Lateral Decubitus Position Generates Discomfort and Worsens Lung Function in Chronic Heart Failure
Chest, September 1, 2005; 128(3): 1511 - 1516.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Agostoni, A. Magini, D. Andreini, M. Contini, A. Apostolo, M. Bussotti, G. Cattadori, and P. Palermo
Spironolactone improves lung diffusion in chronic heart failure
Eur. Heart J., January 2, 2005; 26(2): 159 - 164.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
L. A. Pierard and P. Lancellotti
The Role of Ischemic Mitral Regurgitation in the Pathogenesis of Acute Pulmonary Edema
N. Engl. J. Med., October 14, 2004; 351(16): 1627 - 1634.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. L. Dries, R. J. Verdino, and R. C. Kowal
Postexercise severe ventricular ectopy in heart failure patients: New marker for aggregate risk
J. Am. Coll. Cardiol., August 18, 2004; 44(4): 827 - 828.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/21/2666    most recent
01.CIR.0000097115.61309.59v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Agostoni, P.
Right arrow Articles by Wasserman, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agostoni, P.
Right arrow Articles by Wasserman, K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CARBON MONOXIDE
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Exercise/exercise testing/rehabilitation